Literature DB >> 10670019

Drugs for a new millennium.

S H Snyder1.   

Abstract

A millennium, a century, even a decade is a long time-frame for speculation about anything. Advances in biomedical research in the last few decades have been so extraordinary and escalating at an ever-accelerating pace that any prophecy is a risky proposition. However, it is possible to divine the big, unanswered questions and envisage ways in which they might reasonably be approached in the next few decades, a task which I will try to essay. So many drugs treat so many different medical conditions that a detailed and comprehensive coverage would probably be tiresome. Instead, I will address certain broad themes and diseases that offer both immense challenges and great potential for advances. Rather than review detailed experimental issues, I will confine myself to the 'big picture' issues, providing examples of specific research only in a few instances drawing largely from areas I know best.

Mesh:

Substances:

Year:  1999        PMID: 10670019      PMCID: PMC1692706          DOI: 10.1098/rstb.1999.0538

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  5 in total

Review 1.  Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.

Authors:  M Carlsson; A Carlsson
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

Review 2.  Dissection of dopamine and cocaine binding sites on the rat dopamine transporter expressed in COS cells.

Authors:  S Kitayama; K Morita; T Dohi; J B Wang; S C Davis; G R Uhl
Journal:  Ann N Y Acad Sci       Date:  1996-10-31       Impact factor: 5.691

Review 3.  The current status of the dopamine hypothesis of schizophrenia.

Authors:  A Carlsson
Journal:  Neuropsychopharmacology       Date:  1988-09       Impact factor: 7.853

Review 4.  Excitatory amino acids as a final common pathway for neurologic disorders.

Authors:  S A Lipton; P A Rosenberg
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

Review 5.  Poly (ADP-ribose) polymerase, nitric oxide and cell death.

Authors:  A A Pieper; A Verma; J Zhang; S H Snyder
Journal:  Trends Pharmacol Sci       Date:  1999-04       Impact factor: 14.819

  5 in total
  2 in total

1.  Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models.

Authors:  Sungkun Chun; Joby J Westmoreland; Ildar T Bayazitov; Donnie Eddins; Amar K Pani; Richard J Smeyne; Jing Yu; Jay A Blundon; Stanislav S Zakharenko
Journal:  Science       Date:  2014-06-06       Impact factor: 47.728

2.  Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter.

Authors:  R R Gainetdinov; A R Mohn; L M Bohn; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.